SecBot SecBot
144 ·Filed Sep 14, 2026

RYTM

RHYTHM PHARMACEUTICALS, INC.
BEARISH
Impact 5/10
Horizondays Processed2mo ago SEC0001950047-26-009442
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

Monitor for the actual Form 4 filing to confirm whether the sale was executed. A director/officer sale of this size (50k shares, ~$5.2M) at a $7.2B market cap is notable but not alarming on its own; watch for any pattern of additional insider selling or upcoming catalysts that could explain the timing.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+20
Entry
$96.77
T+0 close · Sep 14, 2026 · via day close
Latest settled
−10.50%
T+20 · $86.61 · next T+60 in 22d
Vs SPY
−13.22%
α at T+20
Latest observation
+19.04%
T+42 · FF3 residual α
  1. T+0 · Sep 15 $96.77entry
  2. T+1 · 2mo ago +1.28%α +1.72% · $98.01
  3. T+5 · 8w ago +2.58%α +0.47% · $99.27
  4. T+20 · 5w ago −10.50%α −13.22% · $86.61
  5. T+44 · todayOpen
  6. T+60 · in 22d Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

David Meeker, a director and officer of Rhythm Pharmaceuticals, filed a Form 144 notice of intent to sell 50,000 shares of common stock with an approximate market value of $5.24 million. The shares are to be sold through Morgan Stanley and were acquired via stock option exercise. This is a notable insider sale from a top executive at a $7.2B market cap biotech, though the filing is an advance notice of intent, not a completed transaction.

Key Facts

  • David Meeker (Director and Officer) filed Form 144 to sell 50,000 shares.
  • Estimated sale value: ~$5,235,500 based on filing date market price.
  • Shares to be sold through Morgan Stanley Smith Barney LLC.
  • Shares acquired via exercise of stock options on 09/14/2026.
  • Filing date: 2026-09-14; proposed sale date also 09/14/2026.

Financial Impact

Proposed sale of 50,000 shares valued at approximately $5.24 million, representing about 0.07% of the company's $7.2B market cap.

dilutioninsider holdings

Risk Factors

  • Insider sale may signal reduced conviction ahead of a potential catalyst or earnings.
  • Form 144 is only an intent to sell; the sale may not be executed.
  • Stock option exercise and immediate sale could indicate tax planning rather than bearish view.

Market Snapshot

Exchange
Nasdaq
Sector
Pharmaceutical Preparations
Analyst Consensus
87% bullish (23 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-009442
Document: 0001950047-26-009442-index.html0001950047-26-009442
Document: 0001950047-26-009442.txt0001950047-26-009442

Track record

26 reports on RYTM

Performance horizon

9 of 13 bullish or bearish reports moved the stock their way by T+5. Best: +32.06% at T+60 after the May 1, 2026 report. 10 of 13 went positive at some point.

Filters
  1. Nov 16, 2026today Press Release Bullish 5/10 Entry $107.48 Now $107.48 +0.00% settles Nov 24
  2. Nov 4, 202612d ago Institutional Cluster Neutral 3/10 Entry $110.68 to $112.16 Now $107.48 −2.89% ▲ +1.34% +2.25% vs SPY
  3. Nov 4, 202612d ago Press Release Bullish 5/10 Entry $110.68 to $112.16 Now $107.48 −2.89% ▲ +1.34% +2.25% vs SPY
  4. Nov 3, 202613d ago 8-K Bullish 6/10 No price data
  5. Nov 3, 202613d ago Press Release Bullish 6/10 Entry $86.44 to $113.95 Now $107.48 +24.34% ▲ +31.83% +32.41% vs SPY
  6. Nov 2, 202614d ago Press Release Neutral 5/10 Entry $86.44 to $113.95 Now $107.48 +24.34% ▲ +31.83% +32.41% vs SPY
  7. Oct 13, 20264w ago Press Release Bullish 6/10 Entry $86.71 to $88.62 Now $107.48 +23.95% ▲ +2.20% +1.75% vs SPY
  8. Oct 13, 20264w ago SC 13G Neutral 3/10 Entry $86.61 to $90.20 Now $107.48 +24.10% ▲ +4.14% +5.30% vs SPY
  9. Sep 14, 20269w ago 144 Bearish 5/10 Viewing Entry $96.77 to $99.27 Now $107.48 −11.07% ▼ −2.58% −0.47% vs SPY
  10. Aug 17, 202613w ago Insider Cluster Bearish 6/10 Entry $115.25 to $113.35 Now $107.48 +6.74% ▲ +1.65% +1.45% vs SPY
Showing 10 of 26

US Market Status

Market Closed · Opens Wed (11h 13m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Sep 14, 2026